Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities
The enhanced Cellebrite investigative evidence management solution further accelerates time to evidence, reduces backlogs, and empowers agencies to utilize resources more efficiently PETAH TIKVA, Israel and TYSONS CORNER, Va., Oct. 19, 2022 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a